Global Patent Index - EP 1163516 A1

EP 1163516 A1 2001-12-19 - EFFECT OF BREFELDIN A ON ANTIGEN-PRESENTING CELLS

Title (en)

EFFECT OF BREFELDIN A ON ANTIGEN-PRESENTING CELLS

Title (de)

WIRKUNG VON BREFELDIN A AUF ANTIGEN-PRÄSENTIERENDE ZELLEN

Title (fr)

EFFET DE LA BREFELDINE A SUR LES CELLULES PRESENTATRICES D'ANTIGENES

Publication

EP 1163516 A1 (FR)

Application

EP 00910959 A

Priority

  • FR 0000636 W
  • FR 9903304 A

Abstract (en)

[origin: FR2791142A1] The invention concerns a method for screening immunogenic peptides using Brefeldin A to enhance the effect of presentation of said peptides by antigen-presenting cells. The invention also concerns immunogenic peptides obtainable by said method, in particular peptide P100, and the use of a peptide P100 compound for preparing a medicine designed to treat and/or prevent EBV-induced diseases, in particular for treating and/or preventing Burkitt lymphoma, nasopharyngeal carcinoma, and/or Hodgkin's disease.

IPC 1-7 (main, further and additional classification)

G01N 33/50; A61K 9/00; A61K 31/365; A61K 38/00; A61K 39/245; C07K 14/05

IPC 8 full level (invention and additional information)

A61K 39/245 (2006.01); C07K 14/05 (2006.01); G01N 33/50 (2006.01); A61K 39/00 (2006.01)

CPC (invention and additional information)

G01N 33/5047 (2013.01); A61K 39/12 (2013.01); A61K 39/245 (2013.01); C07K 14/005 (2013.01); A61K 39/00 (2013.01); C12N 2710/16222 (2013.01); C12N 2710/16234 (2013.01)

Citation (search report)

See references of WO 0055622A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

FR 2791142 A1 20000922; FR 2791142 B1 20010622; AU 3298800 A 20001004; EP 1163516 A1 20011219; WO 0055622 A1 20000921

INPADOC legal status


2005-04-20 [18D] APPLICATION DEEMED TO BE WITHDRAWN

- Effective date: 20041001

2001-12-19 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20011015

2001-12-19 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE